Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol–Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database

IMPORTANCE: Low-density lipoprotein cholesterol (LDL-C)–lowering therapies are a cornerstone of prevention in atherosclerotic cardiovascular disease. With the introduction of generic formulations and the release of new therapies, including proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Cardiol
Main Authors: Sumarsono, Andrew, Lalani, Hussain S., Vaduganathan, Muthiah, Navar, Ann Marie, Fonarow, Gregg C., Das, Sandeep R., Pandey, Ambarish
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7489407/
https://ncbi.nlm.nih.gov/pubmed/32902560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.3723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados